Advances in the treatment of atherosclerosis with ligand‐modified nanocarriers

X Deng, J Wang, S Yu, S Tan, T Yu, Q Xu, N Chen… - …, 2024 - Wiley Online Library
Atherosclerosis, a chronic disease associated with metabolism, poses a significant risk to
human well‐being. Currently, existing treatments for atherosclerosis lack sufficient efficiency …

Nanomedicine for Diagnosis and Treatment of Atherosclerosis

J Cheng, H Huang, Y Chen, R Wu - Advanced Science, 2023 - Wiley Online Library
With the changing disease spectrum, atherosclerosis has become increasingly prevalent
worldwide and the associated diseases have emerged as the leading cause of death. Due …

π–π Interaction‐Induced Organic Long‐wavelength Room‐Temperature Phosphorescence for In Vivo Atherosclerotic Plaque Imaging

Y Zhang, J Li, J Zhao, X Li, Z Wang… - Angewandte Chemie …, 2024 - Wiley Online Library
Room‐temperature phosphorescent (RTP) materials have great potential for in vivo imaging
because they can circumvent the autofluorescence of biological tissues. In this study, a class …

[HTML][HTML] Nanomedicine: Technologies and Applications

M Farrokhi, F Taheri, M Farrokhi, YEK Tosi… - Kindle, 2024 - preferpub.org
Nanomedicine is an innovative field that merges nanotechnology with medicine, aiming to
enhance diagnosis, treatment, and prevention of diseases at the molecular level. This …

Stimuli-responsive polymer-based nanosystems for cardiovascular disease theranostics

Y Liu, C Li, X Yang, B Yang, Q Fu - Biomaterials Science, 2024 - pubs.rsc.org
Stimulus-responsive polymers have found widespread use in biomedicine due to their ability
to alter their own structure in response to various stimuli, including internal factors such as …

Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles

S Wang, H He, Y Mao, Y Zhang, N Gu - Advanced Science, 2024 - Wiley Online Library
Atherosclerosis, a multifaceted chronic inflammatory disease, has a profound impact on
cardiovascular health. However, the critical limitations of atherosclerosis management …

[HTML][HTML] Solubilization techniques used for poorly water-soluble drugs

B Xie, Y Liu, X Li, P Yang, W He - Acta Pharmaceutica Sinica B, 2024 - Elsevier
Currently, about 40% of approved drugs and nearly 90% of drug candidates are poorly
water-soluble drugs. Low solubility reduces the likelihood that these drugs can be effectively …

Innovating Leishmaniasis Treatment: A Critical Chemist's Review of Inorganic Nanomaterials

IAA Bessa, DL D'Amato, AB C. Souza… - ACS Infectious …, 2024 - ACS Publications
Leishmaniasis, a critical Neglected Tropical Disease caused by Leishmania protozoa,
represents a significant global health risk, particularly in resource-limited regions …

[HTML][HTML] Emerging trends and innovations in the treatment and diagnosis of atherosclerosis and cardiovascular disease: a comprehensive review towards healthier …

I Alradwan, N Al Fayez, MN Alomary, AA Alshehri… - Pharmaceutics, 2024 - mdpi.com
Cardiovascular diseases (CVDs) are classed as diseases of aging, which are associated
with an increased prevalence of atherosclerotic lesion formation caused by such diseases …

Strategic assessment of boron-enriched carbon dots/naproxen: diagnostic, toxicity, and in vivo therapeutic evaluation

A Wibrianto, FSD Putri, UK Nisa… - Molecular …, 2024 - ACS Publications
Cancer is a significant global public health concern, ranking as the leading cause of
mortality worldwide. This study thoroughly explores boron-doped carbon dots (B-CDs) …